Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [<sup>18</sup>F]F-PSMA 1007 PET

Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [<sup>18</sup>F]F-PSMA 1007 PET

PET imaging using PSMA ligands is increasingly used for staging in prostate cancer patients in different clinical indications. Unlike [<sup>68</sup>Ga]Ga-labeled PSMA ligands, fluorinated compounds can be produced in large amounts; thus, they can be used for a higher number of patients....

Full description

Bibliographic Details
Main Authors: Elisabeth Relt, Wolfgang Roll, Michael Claesener, Martin Bögemann, Matthias Weckesser, Kambiz Rahbar
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
PSMA-PET
time after synthesis
18F-PSMA
Online Access:https://www.mdpi.com/2072-6694/14/20/5141

Similar Items

Similar Items